Navigation Links
Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
Date:4/18/2008

EATONTOWN, N.J., April 18 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic solutions for regenerative medicine, announced today that it has renewed its exclusive tissue recovery agreement with The Euro Atlantic Transplant Alliance ("EATA"), a Bulgarian public non-profit foundation. The agreement, which was effective April 1, 2008, is for an initial term of seven years and automatically renews for successive four year terms unless a written notice of intent to terminate is provided by either party at least twelve months prior to the end of the initial, or any renewal term. This new agreement replaces a previous agreement that was due to expire in early 2009.

Sam Owusu-Akyaw, President and Chief Executive Officer of Osteotech, stated, "We are very pleased to renew our relationship with the Republic of Bulgaria and the EATA. Through the tissue recovery efforts of both organizations over the past five years, Osteotech has been able to use its processing and product technologies to bring safe and clinically effective OsteoBiologic products to the European market for use by surgeons to alleviate pain, promote biologic healing and restore function."

Dr. Roman A. Hitchev, President and Chief Medical Officer of TB Osteocentre Bulgaria EAD, an indirect wholly-owned subsidiary of Osteotech, commented, "We have had an excellent working relationship with the EATA over the last five years and together have established a successful tissue recovery system in the Republic of Bulgaria. We look forward to continuing our outstanding relationship with the EATA and, working with the EATA, to successfully integrate the Bulgarian tissue recovery and transplantation system into the tissue exchange
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
2. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
3. Osteotech to Present at the Sidoti Conference in New York
4. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
5. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
6. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
7. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
8. Osteotech to Present at Sidoti Conference in San Francisco
9. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
10. Biomaxx Systems Inc. Renews Membership With Bioenergy Australia
11. Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasdaqa...erJaffrayHealthCareConference.Theconferencewillbeh... CTIwillpresentonTuesday,December1at11:00a.m.Easte...presentationwillbeavailableat www.celltherapeutics... , ,PiperJaffrayHealthCareConference,NewYorkPalac...
(Date:11/23/2009)...nk of it as origami very high-tech origami. , Re...oped a technique for fabricating three-dimensional...films by coupling photolithography and a self-fold...he films, only a few microns thick, offer mechanic...ieces of the same material. , "This is a complete...
(Date:11/23/2009)...imensional carbon layer in which the carbon atoms ...honeycomb. Carbon nanotubes are rolled-up sheets o...m graphite. Graphene boasts some very special char...cellent thermal conductor, and reconciles such con...n addition, graphene is impermeable to gases, whic...
(Date:11/23/2009)...PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAmex: ...ythatidentifiesandadvancesadiverseportfolioofpromi...ment,todayreportedthatCytopia(ASX:CYT)hascommenced...t,orally-administeredJAK1/JAK2inhibitor.Thetrialis...roposaltomergeCytopiaintoYMhasbeenpreviouslyannoun...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2Polymer with honeycomb structure 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
... Amnis Corporation announced today the,release of ...ding the,Commercial release of a multilaser capabi...dramatically extending the depth of field well bey...ser upgrade provides the customer with the flexibi...05nm (violet) laser and a 658nm,(red) laser. These...
...., Aug. 23 Nektar,Therapeutics (Nasdaq: NKTR ) t...Senior Vice President and CFO. Harkness reports to...l serve as an integral member of the company,s,new...of healthcare and finance, Tim is a,critical addit... "He brings,significant experience in both financi...
...ia, Aug. 23 , Highlights -- Revenue increased 28...illion -- Excluding one-off items EBITDA increase...6 million -- Excluding one-off items NPAT increas....5 million from A$2.0 million -- Reported NPAT gr...r comparable period including one-off items -...
Other Biology Technology:Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System 2Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer 2Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer 3Ellex FY2007 Year End Results 2Ellex FY2007 Year End Results 3
(Date:11/25/2009)...st as vital to your health as what you eat, found ...tudies. Their experiments in mice revealed that th... the liverthe body,s metabolic clearinghouseis mos...s circadian clock as conventional wisdom had it. ...large number of genes completely independent of th...
(Date:11/24/2009)...oday named 12 new grant recipients for 2009. The a... work across a broad spectrum of lupus research. A...d potential to drive scientific discovery to ultim... of systemic lupus. , The 2009 grants go to both...nation and include interdisciplinary and highly pr...
(Date:11/24/2009)...in that may help gut bacteria bind to the gastroin...otic producers to identify strains that are likely...eed to interact with cells lining the gut to have ...s in the gut they are more likely to stick around ...alie Juge from the Institute of Food Research. IF...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2One Shot May Someday Replace Six for Rabies 58126 1One Shot May Someday Replace Six for Rabies 58126 2University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 1University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 2University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 3Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 1Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 2Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 3Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 4Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 5Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 6
...available in French . , A novel x-ray technique... time scale never reached before has been develope...Scherrer Institute (PSI) in Switzerland. Results o...d of EPFL,s laboratory of Ultrafast Spectroscopy i... online December 11 in the journal Science . , T...
...a turtle,s first swim is the most critical of its ...ators to make it to the sea, the tiny voyager must...its bid for freedom. For youngsters hatching on th...gh: as many as 30% perish as they head for safe de...rough the waves cost the intrepid hatchlings? Curi...
...uma National Park, the last stronghold for the sav...ow hover at about 1,000 animals, down from an esti...ic weapons have decimated elephant populations pa...f the park., Civil unrest in has made conservatio...rds have been shot and killed in recent years. Ho...
Other Biology News:Molecules in the spotlight 2Cost of hatchling turtles' dash for freedom 2Missing: 2,000 elephants 2
...ulti-casting chamber is used for handcasting and v...ndcast (8.3 x 7.3 cm) or precast (8.6 x 6.8 cm) ge...udes an electrophoresis tank with built-in cooling...rculator (not included), lid with power cables, 6 ...
Protease Inhibitor Cocktail Set I from Calbiochem
...gnificantly increase the shelf life of diluted per...at room temperature storage conditions in addition...0.2 micron filtration, and contains no mercury or ... levels of activity for both the enzyme and the an...
NucleoSpin Extract II from MACHEREY-NAGEL
Biology Products: